What I like about Virtus Health Ltd shares

Virtus Health Ltd (ASX:VRT) reports disappointing news.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday, Virtus Health Ltd (ASX: VRT) which is Australia's market-leading fertility services company released a trading update for the first quarter of 2017. Its fresh cycle activity is down 5.9% compared to the first quarter of last year, worse than the overall market which declined 3.5%. The company stated that its loss of market share was due to increased competition from a new entrant in Victoria.

Meanwhile, the company's smaller operations in Ireland (where it is also market leader) and Singapore are doing well. Ireland grew 5.8% versus the prior period and Singapore generated its first profit.

The industry growth rate for IVF treatments in Australia was unusually strong last year at 8.2% compared to a long-term average of 4.1%. Therefore, weak market trends in the first quarter of this year may merely represent normalisation to historical rates. Furthermore, a single quarter is far too short a period to draw any solid conclusions about permanent changes to industry trends.

Listed competitor Monash IVF Group Ltd (ASX: MVF) also has a strong presence in the Victorian market. It will be interesting to see if it too has suffered from the new entrant to the state, but regardless it seems unlikely the company will repeat last year's cracking results given the slowdown in the overall market.

The fertility industry should keep growing in future years despite last quarter's blip given prevailing social trends and technological progression that is unlikely to reverse. However, this may not be a good thing for incumbents as it could entice further competition, as hinted by yesterday's announcement.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »